Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: Contralateral Claims Study of Clareon Vivity Pro [NA]

View source ↗

Summary

This clinical trial update describes a contralateral claims study of Clareon Vivity Pro for aphakia and presbyopia, with the study status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clareon Vivity Pro

Snippet

Sponsor: Alcon Research | Conditions: Aphakia, Presbyopia | NA | Status: NOT_YET_RECRUITING